Logo image of HLF

HERBALIFE LTD (HLF) Stock Fundamental Analysis

NYSE:HLF - KYG4412G1010 - Common Stock

9.86 USD
-0.23 (-2.28%)
Last: 9/5/2025, 8:20:02 PM
9.83 USD
-0.03 (-0.3%)
After Hours: 9/5/2025, 8:20:02 PM
Fundamental Rating

5

Overall HLF gets a fundamental rating of 5 out of 10. We evaluated HLF against 36 industry peers in the Personal Care Products industry. While HLF belongs to the best of the industry regarding profitability, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on HLF.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

HLF had positive earnings in the past year.
HLF had a positive operating cash flow in the past year.
HLF had positive earnings in each of the past 5 years.
HLF had a positive operating cash flow in each of the past 5 years.
HLF Yearly Net Income VS EBIT VS OCF VS FCFHLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

With an excellent Return On Assets value of 11.88%, HLF belongs to the best of the industry, outperforming 86.11% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 26.65%, HLF belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
HLF had an Average Return On Invested Capital over the past 3 years of 21.47%. This is significantly above the industry average of 12.91%.
The 3 year average ROIC (21.47%) for HLF is below the current ROIC(26.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.88%
ROE N/A
ROIC 26.65%
ROA(3y)8.71%
ROA(5y)10.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)21.47%
ROIC(5y)23.4%
HLF Yearly ROA, ROE, ROICHLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

Looking at the Profit Margin, with a value of 6.59%, HLF is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Profit Margin of HLF has declined.
HLF has a better Operating Margin (12.68%) than 77.78% of its industry peers.
HLF's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 78.12%, HLF belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
In the last couple of years the Gross Margin of HLF has remained more or less at the same level.
Industry RankSector Rank
OM 12.68%
PM (TTM) 6.59%
GM 78.12%
OM growth 3Y-9.16%
OM growth 5Y-4.06%
PM growth 3Y-12.9%
PM growth 5Y-4.4%
GM growth 3Y-0.32%
GM growth 5Y-0.62%
HLF Yearly Profit, Operating, Gross MarginsHLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HLF is creating value.
The number of shares outstanding for HLF has been increased compared to 1 year ago.
Compared to 5 years ago, HLF has less shares outstanding
The debt/assets ratio for HLF has been reduced compared to a year ago.
HLF Yearly Shares OutstandingHLF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLF Yearly Total Debt VS Total AssetsHLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.38 indicates that HLF is not a great score, but indicates only limited risk for bankruptcy at the moment.
HLF's Altman-Z score of 2.38 is in line compared to the rest of the industry. HLF outperforms 47.22% of its industry peers.
The Debt to FCF ratio of HLF is 12.49, which is on the high side as it means it would take HLF, 12.49 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HLF (12.49) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.49
Altman-Z 2.38
ROIC/WACC3.68
WACC7.25%
HLF Yearly LT Debt VS Equity VS FCFHLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.01 indicates that HLF should not have too much problems paying its short term obligations.
HLF has a worse Current ratio (1.01) than 75.00% of its industry peers.
HLF has a Quick Ratio of 1.01. This is a bad value and indicates that HLF is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.54, HLF is doing worse than 80.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.54
HLF Yearly Current Assets VS Current LiabilitesHLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

HLF shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.65%.
HLF shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.08% yearly.
The Revenue has decreased by -2.25% in the past year.
The Revenue has been growing slightly by 0.47% on average over the past years.
EPS 1Y (TTM)7.65%
EPS 3Y-25.39%
EPS 5Y-7.08%
EPS Q2Q%9.26%
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y-4.89%
Revenue growth 5Y0.47%
Sales Q2Q%-1.72%

3.2 Future

HLF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.90% yearly.
HLF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.54% yearly.
EPS Next Y9.81%
EPS Next 2Y16.97%
EPS Next 3Y21.9%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.06%
Revenue Next 3Y3.54%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLF Yearly Revenue VS EstimatesHLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
HLF Yearly EPS VS EstimatesHLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.67, the valuation of HLF can be described as very cheap.
HLF's Price/Earnings ratio is rather cheap when compared to the industry. HLF is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of HLF to the average of the S&P500 Index (27.06), we can say HLF is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 3.68, the valuation of HLF can be described as very cheap.
Based on the Price/Forward Earnings ratio, HLF is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.69. HLF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.67
Fwd PE 3.68
HLF Price Earnings VS Forward Price EarningsHLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HLF is valued cheaper than 97.22% of the companies in the same industry.
HLF's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HLF is cheaper than 97.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.93
EV/EBITDA 3.84
HLF Per share dataHLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HLF has a very decent profitability rating, which may justify a higher PE ratio.
HLF's earnings are expected to grow with 21.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y16.97%
EPS Next 3Y21.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HLF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HERBALIFE LTD

NYSE:HLF (9/5/2025, 8:20:02 PM)

After market: 9.83 -0.03 (-0.3%)

9.86

-0.23 (-2.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners105.01%
Inst Owner Change-2.25%
Ins Owners2.11%
Ins Owner Change1.33%
Market Cap1.02B
Analysts50.91
Price Target9.52 (-3.45%)
Short Float %11.95%
Short Ratio6.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)55.95%
Min EPS beat(2)52.72%
Max EPS beat(2)59.17%
EPS beat(4)4
Avg EPS beat(4)58.76%
Min EPS beat(4)52.72%
Max EPS beat(4)62.26%
EPS beat(8)6
Avg EPS beat(8)34.13%
EPS beat(12)9
Avg EPS beat(12)27.43%
EPS beat(16)12
Avg EPS beat(16)24.72%
Revenue beat(2)0
Avg Revenue beat(2)-1.59%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)-1.24%
Revenue beat(4)1
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)0.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.88%
Revenue beat(12)6
Avg Revenue beat(12)-0.02%
Revenue beat(16)7
Avg Revenue beat(16)-0.19%
PT rev (1m)12.5%
PT rev (3m)12.5%
EPS NQ rev (1m)-19.66%
EPS NQ rev (3m)-19.25%
EPS NY rev (1m)1.04%
EPS NY rev (3m)1.04%
Revenue NQ rev (1m)0.95%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.64%
Valuation
Industry RankSector Rank
PE 4.67
Fwd PE 3.68
P/S 0.21
P/FCF 5.93
P/OCF 3.83
P/B N/A
P/tB N/A
EV/EBITDA 3.84
EPS(TTM)2.11
EY21.4%
EPS(NY)2.68
Fwd EY27.2%
FCF(TTM)1.66
FCFY16.86%
OCF(TTM)2.57
OCFY26.1%
SpS47.8
BVpS-6.41
TBVpS-10.45
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.88%
ROE N/A
ROCE 38.05%
ROIC 26.65%
ROICexc 33.13%
ROICexgc 48.44%
OM 12.68%
PM (TTM) 6.59%
GM 78.12%
FCFM 3.48%
ROA(3y)8.71%
ROA(5y)10.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)21.47%
ROIC(5y)23.4%
ROICexc(3y)31.31%
ROICexc(5y)37.76%
ROICexgc(3y)50.31%
ROICexgc(5y)62.7%
ROCE(3y)30.65%
ROCE(5y)33.4%
ROICexcg growth 3Y-11.83%
ROICexcg growth 5Y-10.42%
ROICexc growth 3Y-12.15%
ROICexc growth 5Y-7.63%
OM growth 3Y-9.16%
OM growth 5Y-4.06%
PM growth 3Y-12.9%
PM growth 5Y-4.4%
GM growth 3Y-0.32%
GM growth 5Y-0.62%
F-Score6
Asset Turnover1.8
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.49
Debt/EBITDA 2.65
Cap/Depr 77.73%
Cap/Sales 1.91%
Interest Coverage 250
Cash Conversion 35.59%
Profit Quality 52.74%
Current Ratio 1.01
Quick Ratio 0.54
Altman-Z 2.38
F-Score6
WACC7.25%
ROIC/WACC3.68
Cap/Depr(3y)118.39%
Cap/Depr(5y)121.51%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.55%
Profit Quality(3y)93.92%
Profit Quality(5y)97.9%
High Growth Momentum
Growth
EPS 1Y (TTM)7.65%
EPS 3Y-25.39%
EPS 5Y-7.08%
EPS Q2Q%9.26%
EPS Next Y9.81%
EPS Next 2Y16.97%
EPS Next 3Y21.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y-4.89%
Revenue growth 5Y0.47%
Sales Q2Q%-1.72%
Revenue Next Year0%
Revenue Next 2Y2.06%
Revenue Next 3Y3.54%
Revenue Next 5YN/A
EBIT growth 1Y53.68%
EBIT growth 3Y-13.6%
EBIT growth 5Y-3.61%
EBIT Next Year37.68%
EBIT Next 3Y19.2%
EBIT Next 5YN/A
FCF growth 1Y9.94%
FCF growth 3Y-19.13%
FCF growth 5Y-14.2%
OCF growth 1Y-13.02%
OCF growth 3Y-14.73%
OCF growth 5Y-9.01%